Bunker Kevin D.

Bunker Kevin D. serves as the Chief Scientific Officer at Zentalis Pharmaceuticals, Inc., a company focused on developing innovative therapeutics for cancer treatment. As part of his role, he is involved in the strategic direction and scientific advancement of the company's research initiatives. His recent public disclosure, dated December 21, 2023, reflects his insider activity within the healthcare sector, specifically related to Zentalis Pharmaceuticals (ZNTL). The disclosure record shows a total of one filing, indicating a focused engagement with the company's developments.